| Literature DB >> 25285458 |
Kevin C Soares1, Kelly Foley2, Kelly Olino1, Ashley Leubner2, Skye C Mayo1, Ajay Jain1, Elizabeth Jaffee2, Richard D Schulick3, Kiyoshi Yoshimura4, Barish Edil5, Lei Zheng6.
Abstract
Numerous murine models have been developed to study human cancers and advance the understanding of cancer treatment and development. Here, a preclinical, murine pancreatic tumor model of hepatic metastases via a hemispleen injection of syngeneic murine pancreatic tumor cells is described. This model mimics many of the clinical conditions in patients with metastatic disease to the liver. Mice consistently develop metastases in the liver allowing for investigation of the metastatic process, experimental therapy testing, and tumor immunology research.Entities:
Mesh:
Year: 2014 PMID: 25285458 PMCID: PMC4378377 DOI: 10.3791/51677
Source DB: PubMed Journal: J Vis Exp ISSN: 1940-087X Impact factor: 1.355